The pharmaceutical side of psychedelics

Following strict scientific standards to protect patients and help produce reliable clinical trials results

Sponsored
Discussion Forum: Biomind Labs Inc
List Message View
Thread Message View
New Message
Author / Date /
Topic Title
Rating
Re
Last Post
AGORACOM-AM - Jan 23, 2023 04:00PM
Icon agoracom END OF DAY ALERT: Biomind Labs (BMND: NEO) (BMNDF: OTC) Up 12% Vol: 2.2K Shares

0
AGORACOM-AM
Jan 23, 2023 04:00PM
AGORACOM-AM - Jan 11, 2023 04:20PM
Icon agoracom END OF DAY ALERT: Biomind Labs (BMND: NEO) (BMNDF: OTC) Up 18% On 2K Shares

0
AGORACOM-AM
Jan 11, 2023 04:20PM
AGORACOM-AM - Jan 04, 2023 04:20PM
Icon agoracom END OF DAY ALERT: Biomind Labs (BMND: NEO) (BMNDF: OTC) Up 33% On 2K Shares

0
AGORACOM-AM
Jan 04, 2023 04:20PM
AGORACOM-AM - Dec 30, 2022 04:20PM
Icon agoracom END OF DAY ALERT: Biomind Labs (BMND: NEO) (BMNDF: OTC) Up 36% On 3.2K Shares

0
AGORACOM-AM
Dec 30, 2022 04:20PM
AGORACOM-AM - Dec 29, 2022 04:20PM
Icon agoracom END OF DAY ALERT: Biomind Labs (BMND: NEO) (BMNDF: OTC) Up 20% On 2K Shares

0
AGORACOM-AM
Dec 29, 2022 04:20PM
AGORACOM-AM - Dec 28, 2022 09:22AM
Icon agoracom Biomind Labs Announces the Completion of the First Sublingual Psychedelic Formulation for Its Drug Candidate BMND08 for Depression and Anxiety…

0
AGORACOM-AM
Dec 28, 2022 09:22AM
AGORACOM-AM - Dec 20, 2022 04:20PM
Icon agoracom END OF DAY ALERT: Biomind Labs (BMND: NEO) (BMNDF: OTC) Up 14% On 14.5K Shares

0
AGORACOM-AM
Dec 20, 2022 04:20PM
AGORACOM-AM - Dec 02, 2022 04:20PM
Icon agoracom END OF DAY ALERT: Biomind Labs (BMND: NEO) (BMNDF: OTC) Up 20% On 5.4K Shares

0
AGORACOM-AM
Dec 02, 2022 04:20PM
AGORACOM-AM - Nov 14, 2022 09:13PM
Icon agoracom Biomind Labs Announces FDA Investigational New Drug Clearance for Its New Chemical Entity Triptax™ Targeting Treatment-Resistant Depression...

0
AGORACOM-AM
Nov 14, 2022 09:13PM
AGORACOM-AM - Nov 10, 2022 04:20PM
Icon agoracom END OF DAY ALERT: Biomind Labs (BMND: NEO) (BMNDF: OTC) Up 21% On 2.4K Shares

0
AGORACOM-AM
Nov 10, 2022 04:20PM
AGORACOM-AM - Nov 04, 2022 04:20PM
Icon agoracom END OF DAY ALERT: Biomind Labs (BMND: NEO) (BMNDF: OTC) Up 30% On 3K Shares

0
AGORACOM-AM
Nov 04, 2022 04:20PM
AGORACOM-AM - Nov 04, 2022 07:58AM
Icon agoracom Biomind Labs Announces Positive Initial Results From Its Phase II Trial on Its BMND01 Candidate for Treatment Resistant Depression

0
AGORACOM-AM
Nov 04, 2022 07:58AM
AGORACOM-AM - Nov 02, 2022 04:20PM
Icon agoracom END OF DAY ALERT: Biomind Labs (BMND: NEO) (BMNDF: OTC) Up 60% On 1K Shares

0
AGORACOM-AM
Nov 02, 2022 04:20PM
AGORACOM-AM - Oct 21, 2022 04:20PM
Icon agoracom END OF DAY ALERT: Biomind Labs (BMND: NEO) (BMNDF: OTC) Up 47% On 1.1K Shares

0
AGORACOM-AM
Oct 21, 2022 04:20PM
AGORACOM-AM - Oct 11, 2022 04:20PM
Icon agoracom END OF DAY ALERT: Biomind Labs (BMND: NEO) (BMNDF: OTC) Up 49% On 1K Shares

0
AGORACOM-AM
Oct 11, 2022 04:20PM
AGORACOM-AM - Oct 11, 2022 12:38PM
Icon agoracom Biomind Labs Announces Pre-IND Meeting Request Granted by FDA for Its New Chemical Entity Triptax™ Targeting Treatment-Resistant Depression

0
AGORACOM-AM
Oct 11, 2022 12:38PM
AGORACOM-AM - Sep 28, 2022 04:20PM
Icon agoracom END OF DAY ALERT: Biomind Labs (BMND: NEO) (BMNDF: OTC) Up 17% On 2.7K Shares

0
AGORACOM-AM
Sep 28, 2022 04:20PM
AGORACOM-AM - Sep 27, 2022 06:26AM
Icon agoracom Biomind Labs and Queen’s University of Belfast Receive Controlled Substances License to Commence the Production...

0
AGORACOM-AM
Sep 27, 2022 06:26AM
AGORACOM-AM - Sep 21, 2022 06:25AM
Icon agoracom Biomind Labs Announces Completion of Dosing in Phase II Trial of Its DMT-Based Inhaled Formulation BMND01 for Treatment-Resistant Depression

0
AGORACOM-AM
Sep 21, 2022 06:25AM
AGORACOM-AM - Sep 16, 2022 04:20PM
Icon agoracom END OF DAY ALERT: Biomind Labs (BMND: NEO) (BMNDF: OTC) Up 20% On 1.2K Shares

0
AGORACOM-AM
Sep 16, 2022 04:20PM
New Message